EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing neoadjuvant chemotherapy: Study protocol for the REBUILD trial

Paola Gonzalo-Encabo iD, John Gardiner, Mary K Norris, Rebekah L Wilson, Amber J Normann iD, Danny Nguyen, Nathan Parker, Darryl Tjogas iD, Lauren K Brais, Jeffrey A Meyerhardt, Michael H Rosenthal, Brian M Wolpin und 2 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0322192 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Paola Gonzalo-Encabo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Dietary Proteins, Dietary Supplements, Muscle, Skeletal, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Friends of Dana-Farber.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic cancer patients’ prognosis may be limited by two conditions, cachexia and sarcopenia. Resistance exercise and protein supplementation are safe non-pharmacological strategies that may increase or preserve skeletal muscle mass within this population. Therefore, the primary aim of this study is to examine the feasibility of a home-based virtually supervised resistance exercise intervention, with or without protein supplementation in pancreatic cancer patients initiating neoadjuvant chemotherapy. This intervention may also maintain skeletal muscle mass and improve plasma biomarkers associated with muscle tissue wasting, physical function and psychological measures.

Methods

We aim to recruit 45 patients with locally advanced pancreatic cancer initiating neoadjuvant chemotherapy. Patients will be randomized to receive either Resistance Exercise (RE) (n = 15), Resistance Exercise and Protein Supplementation (RE + PS) (n = 15), or Attention Control (AC) (n = 15). Patients randomized to RE or RE + PS will receive 16-weeks of home-based virtually supervised resistance exercise. The AC will receive a 16-week stretching program. Primary and secondary outcomes will be measured at baseline and after 16 weeks during study visits.

Discussion

The REBUILD trial is the first randomized controlled trial that combines resistance exercise with daily protein supplementation during neoadjuvant chemotherapy in pancreatic cancer patients. Our novel home-based virtually supervised exercise intervention seeks to mitigate barriers to participation in this vulnerable population. Furthermore, results of this trial will address important research gaps associated with pancreatic cancer-related cachexia, a condition closely connected with poor prognosis and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary ProteinsDietary SupplementsMuscle, SkeletalPancreatic NeoplasmsResistance TrainingAdultAgedFemaleHumansMaleMiddle AgedCachexiaNeoadjuvant TherapySarcopenia

Substanzen

Dietary Proteins

Autor:innen und Institutionen

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
  • Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Departamento de Ciencias Biomédicas, Área de Educación Física y Deportiva, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Madrid, España.
  • Department of Health Sciences, Boston University, Boston, Massachusetts, United States of America.
  • Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida, United States of America.
  • Department of Imaging, Dana-Farber Cancer Institute, Boston Massachusetts, United States of America.

ORCID-Profile: Paola Gonzalo-Encabo, Amber J Normann, Darryl Tjogas, Christina M Dieli-Conwright

Förderung

  • NCI NIH HHS
  • Friends of Dana-Farber

Zitieren

APA

Gonzalo-Encabo, P., Gardiner, J., Norris, M. K., Wilson, R. L., Normann, A. J., Nguyen, D., Parker, N., Tjogas, D., Brais, L. K., Meyerhardt, J. A., Rosenthal, M. H., Wolpin, B. M., Uno, H., & Dieli-Conwright, C. M. (2025). Resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing neoadjuvant chemotherapy: Study protocol for the REBUILD trial. PLOS One. https://doi.org/10.1371/journal.pone.0322192

Vancouver

Gonzalo-Encabo P, Gardiner J, Norris MK, Wilson RL, Normann AJ, Nguyen D, et al. Resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing neoadjuvant chemotherapy: Study protocol for the REBUILD trial. PLOS One. 2025. doi:10.1371/journal.pone.0322192

BibTeX
@article{GonzaloEncabo2025,
  author = {Gonzalo-Encabo, Paola and Gardiner, John and Norris, Mary K and Wilson, Rebekah L and Normann, Amber J and Nguyen, Danny and Parker, Nathan and Tjogas, Darryl and Brais, Lauren K and Meyerhardt, Jeffrey A and Rosenthal, Michael H and Wolpin, Brian M and Uno, Hajime and Dieli-Conwright, Christina M},
  title = {Resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing neoadjuvant chemotherapy: Study protocol for the REBUILD trial},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0322192}
}
Kostenlos starten →